Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.

ABSTRACT:

Background

The first case of Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were diagnosed in Wuhan, China in 2019. In the first half of 2020 this disease has already converted into a global pandemic. Various treatment options were being tried all over the world. Some studies showed beneficial effects of corticosteroids in covid 19. Hence, we designed this study to compare the effect of two steroids in moderate to severe covid 19 disease.

Objectives

To compare the efficacy and safety of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.

Study settings

Fatima Memorial Hospital, Lahore and Ganga Ram hospital, Lahore.

Study design

Quasi experimental, interventional study.

Duration of study

From 1st June

SUBMITTER: Fatima SA 

PROVIDER: S-EPMC7654232 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature